Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel. [electronic resource]
Producer: 20180117Description: 24217-27 p. digitalISSN:- 1949-2553
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab -- administration & dosage
- Biomarkers, Tumor -- genetics
- Breast Neoplasms -- blood supply
- Female
- Follow-Up Studies
- Gene Expression Profiling
- Humans
- Middle Aged
- Neovascularization, Pathologic -- genetics
- Paclitaxel -- administration & dosage
- Prognosis
- Receptor, ErbB-2 -- metabolism
- Survival Rate
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.